Flash Forward is a show about possible (and not so possible) future scenarios. What would the warranty on a sex robot look like? How would diplomacy work if we couldn’t lie? Could there ever be a fecal transplant black market? (Complicated, it wouldn’t, and yes, respectively, in case you’re curious.) Hosted and produced by award winning science journalist Rose Eveleth, each episode combines audio drama and journalism to go deep on potential tomorrows, and uncovers what those futures might re ...
…
continue reading
Innhold levert av American Lung Association. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av American Lung Association eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Player FM - Podcast-app
Gå frakoblet med Player FM -appen!
Gå frakoblet med Player FM -appen!
The Promise of Lung Cancer Precision Medicine with Dr. Jonathan Spicer
MP3•Episoder hjem
Manage episode 400640916 series 3310605
Innhold levert av American Lung Association. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av American Lung Association eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Episode Highlights
0:15 Intro
3:09 Low-dose CT screening uptake in Canada
4:45 Evolution of adjuvant, neoadjuvant therapies
7:10 Reviewing CheckMate 816
10:56 Reviewing KEYNOTE-671
12:58 The impact of neoadjuvants on operability
16:15 Treatment-specific biomarkers for lung cancer
21:13 The short-term future of lung cancer therapy
24:31 Outro
Precision medicine–delivering the right drug at the right time to the right patient–is the direction in which lung cancer treatment is heading. In this episode, we talk about an exciting, emerging drug class with one of the most prominent investigators involved with its development, Dr. Jonathan Spicer at McGill University’s Thoracic Oncology Network.
It provides a deep dive into neoadjuvant therapy for patients who have operable lung cancer, offering insight into what is currently known about response and failure rates.
Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
0:15 Intro
3:09 Low-dose CT screening uptake in Canada
4:45 Evolution of adjuvant, neoadjuvant therapies
7:10 Reviewing CheckMate 816
10:56 Reviewing KEYNOTE-671
12:58 The impact of neoadjuvants on operability
16:15 Treatment-specific biomarkers for lung cancer
21:13 The short-term future of lung cancer therapy
24:31 Outro
Precision medicine–delivering the right drug at the right time to the right patient–is the direction in which lung cancer treatment is heading. In this episode, we talk about an exciting, emerging drug class with one of the most prominent investigators involved with its development, Dr. Jonathan Spicer at McGill University’s Thoracic Oncology Network.
It provides a deep dive into neoadjuvant therapy for patients who have operable lung cancer, offering insight into what is currently known about response and failure rates.
Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
54 episoder
MP3•Episoder hjem
Manage episode 400640916 series 3310605
Innhold levert av American Lung Association. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av American Lung Association eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Episode Highlights
0:15 Intro
3:09 Low-dose CT screening uptake in Canada
4:45 Evolution of adjuvant, neoadjuvant therapies
7:10 Reviewing CheckMate 816
10:56 Reviewing KEYNOTE-671
12:58 The impact of neoadjuvants on operability
16:15 Treatment-specific biomarkers for lung cancer
21:13 The short-term future of lung cancer therapy
24:31 Outro
Precision medicine–delivering the right drug at the right time to the right patient–is the direction in which lung cancer treatment is heading. In this episode, we talk about an exciting, emerging drug class with one of the most prominent investigators involved with its development, Dr. Jonathan Spicer at McGill University’s Thoracic Oncology Network.
It provides a deep dive into neoadjuvant therapy for patients who have operable lung cancer, offering insight into what is currently known about response and failure rates.
Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
0:15 Intro
3:09 Low-dose CT screening uptake in Canada
4:45 Evolution of adjuvant, neoadjuvant therapies
7:10 Reviewing CheckMate 816
10:56 Reviewing KEYNOTE-671
12:58 The impact of neoadjuvants on operability
16:15 Treatment-specific biomarkers for lung cancer
21:13 The short-term future of lung cancer therapy
24:31 Outro
Precision medicine–delivering the right drug at the right time to the right patient–is the direction in which lung cancer treatment is heading. In this episode, we talk about an exciting, emerging drug class with one of the most prominent investigators involved with its development, Dr. Jonathan Spicer at McGill University’s Thoracic Oncology Network.
It provides a deep dive into neoadjuvant therapy for patients who have operable lung cancer, offering insight into what is currently known about response and failure rates.
Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
54 episoder
Alle episoder
×Velkommen til Player FM!
Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.